August 4, 2020cannabidiol, Cannabis Industry & Marijuana Business Briefs, cbd, Dravet syndrome, Epidiolex, Europe Cannabis Industry & Marijuana Business News, FDA, GW Pharmaceuticals, International Marijuana Business News, Lennox-Gastaut syndrome, Medical Cannabis Industry & Recreational Marijuana Business News, tuberous sclerosis complex, U.S. Food and Drug Administration, United States Cannabis Industry & Marijuana Business News FDA approves GW Pharmaceuticals’ cannabis drug for new indication CBD drug Epidiolex received approval from the U.S. Food and Drug Administration to treat seizures associated with a third medical condition, expanding […]